Atria Wealth Solutions’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.5M Buy
379,262
+49,574
+15% +$1.63M 0.31% 70
2025
Q1
$10.6M Buy
329,688
+68,879
+26% +$2.31M 0.13% 171
2024
Q4
$8.68M Buy
260,809
+70,941
+37% +$2.39M 0.09% 216
2024
Q3
$6.31M Buy
189,868
+28,099
+17% +$900K 0.07% 291
2024
Q2
$5.08M Buy
161,769
+119,777
+285% +$3.63M 0.06% 339
2024
Q1
$1.27M Buy
41,992
+27,130
+183% +$782K 0.01% 808
2023
Q4
$411K Buy
+14,862
New +$385K 0.01% 1317

Other funds holding TCAF

Atria Wealth Solutions's TCAF Position: Q2 2025 in Review

Atria Wealth Solutions increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 15% in Q2 2025, buying an estimated $1.63M and bringing the position to 379,262 shares worth $13.5M. The position accounts for 0.31% of the portfolio, ranked #70.

Atria Wealth Solutions first reported a position in TCAF in Q4 2023 and has held it in 7 quarters since. 277 funds tracked by Wall St. Rank hold TCAF as of Q2 2025.

  • Atria Wealth Solutions held 379,262 shares of T. Rowe Price Capital Appreciation Equity ETF worth $13.5M as of Q2 2025.
  • Atria Wealth Solutions bought 49,574 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2025, an estimated $1.63M.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.31% of Atria Wealth Solutions's portfolio in Q2 2025, its #70 holding.
  • Atria Wealth Solutions first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q4 2023 and has held it in 7 quarters since.
  • 277 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2025.

Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.